
Unproved Stem Cell Clinics Proliferate in the U.S.
570 sites advertise therapies for sports injuries, autism and MS via direct-to-consumer marketing

Unproved Stem Cell Clinics Proliferate in the U.S.
570 sites advertise therapies for sports injuries, autism and MS via direct-to-consumer marketing

The Sound of Your Voice May Diagnose Disease
How you talk could reveal heart disease or concussions, say researchers and companies developing the novel technology


How to Regrow Your Own Bones
Biotech pioneer Nina Tandon tells how a patient's own stem cells could be grown on 3-D scaffolds

Gene Editing Takes on Heart Disease
Stem cell researcher Qiurong Ding says altering cell DNA may enable reprogramming disease right out of patients

How Risky are the World Economic Forum's Top 10 Emerging Technologies for 2016?
It’s hard to predict the possible downsides, but we must try to do it anyway in order to develop them responsibly

Optogenetics Lights Up Therapeutic Neuroscience
Enhanced by emerging wireless microchips, technique could offer new routes to treatment for conditions like Parkinson’s and depression

Organs-on-Chips Allow New Views of Human Biology
Miniature simulations allow scientists to study physiological mechanisms and behaviors in ways never before possible, creating opportunities for drug development

First CRISPR Human Clinical Trial Gets a Green Light from the U.S.
The gene-editing technology’s cancer treatment safety test could start later this year

Can You Teach Old Drugs New Tricks?
As drug development costs skyrocket, researchers look to repurpose older ones—even some that failed earlier trials

Stem Cells for Snoopy: Pet Medicines Spark a Biotech Boom
Firms chase a new breed of advanced veterinary care, from antibodies to cell therapies

Medical Labs May Be Killing Horseshoe Crabs
Drawing the crabs’ blue blood for vital medical testing can condemn the animals to die, even after they are returned to the sea

Plan to Synthesize Human Genome Triggers a Mixed Response
Some admire the project’s audacity, but many say more public debate is needed